CSFZX
Price
$50.95
Change
+$0.18 (+0.35%)
Updated
Dec 23 closing price
RGREX
Price
$8.71
Change
+$0.04 (+0.46%)
Updated
Dec 23 closing price
Ad is loading...

CSFZX vs RGREX

Header iconCSFZX vs RGREX Comparison
Open Charts CSFZX vs RGREXBanner chart's image
Cohen & Steers Global Realty Z
Price$50.95
Change+$0.18 (+0.35%)
VolumeN/A
CapitalizationN/A
Invesco Global Real Estate R
Price$8.71
Change+$0.04 (+0.46%)
VolumeN/A
CapitalizationN/A
CSFZX vs RGREX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CSFZX vs. RGREX commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSFZX is a Buy and RGREX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
CSFZX has more cash in the bank: 1.92B vs. RGREX (141M). CSFZX pays higher dividends than RGREX: CSFZX (2.91) vs RGREX (1.59). CSFZX was incepted earlier than RGREX: CSFZX (10 years) vs RGREX (20 years). RGREX is a more actively managed with annual turnover of: 69.00 vs. CSFZX (52.00). CSFZX has a lower initial minimum investment than RGREX: CSFZX (0) vs RGREX (1000). CSFZX annual gain was more profitable for investors over the last year : 1.75 vs. RGREX (-1.38). CSFZX return over 5 years is better than : 5.29 vs. RGREX (-22.78).
CSFZXRGREXCSFZX / RGREX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years20 years-
Gain YTD0.696-2.139-33%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.92B141M1,362%
Annual Yield % from dividends2.911.59183%
Returns for 1 year1.75-1.38-127%
Returns for 3 years-14.08-25.8854%
Returns for 5 years5.29-22.78-23%
Returns for 10 years37.29-16.17-231%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GNSS2.610.07
+2.76%
Genasys
EBF20.830.15
+0.73%
Ennis
CACI405.022.30
+0.57%
Caci International CLA
CALX34.98-0.38
-1.07%
CALIX
RNAZ3.58-0.18
-4.79%
TransCode Therapeutics Inc